Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2014
07/17/2014WO2014110036A1 Ship1 modulators and methods related thereto
07/17/2014WO2014109987A1 Mixed disulfide conjugates of thienopyridine compounds and uses thereof
07/17/2014WO2014108858A1 Fatty acid synthase inhibitors
07/17/2014WO2014108679A1 Benzylamine derivatives
07/17/2014WO2014108337A1 Pyrazolyl-based carboxamides i as crac channel inhibitors
07/17/2014WO2014108336A1 Pyrazolyl-based carboxamides ii as crac channel inhibitors
07/17/2014WO2014108299A1 Substituted [1,2,4]triazole and imidazole compounds
07/17/2014WO2014108168A1 Piperidinylcarbazole as antimalarial
07/17/2014WO2014079995A3 Novel inhibitor compounds of phosphodiesterase type 10a
07/17/2014WO2014068587A3 An improved process for the synthesis of dabigatran and its intermediates
07/17/2014WO2014032755A3 Ddr2 inhibitors for the treatment of osteoarthritis
07/17/2014US20140200244 Phenylethanolamine-based nmda receptor antagonists
07/17/2014US20140200227 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
07/17/2014US20140200224 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
07/17/2014US20140200222 N-linked quinolineamide m1 receptor positive allosteric modulators
07/17/2014US20140200218 Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
07/17/2014US20140200216 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
07/17/2014US20140200205 New thio derivatives bearing lactams as potent hdac inhibitors and their uses as medicaments
07/17/2014US20140200135 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
07/17/2014US20140199236 Androgen receptor modulator and uses thereof
07/16/2014EP2754660A1 Pyridazinon derivatives
07/16/2014EP2754656A1 Androgen receptor modulating compounds
07/16/2014EP2754655A2 Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same
07/16/2014EP2753615A1 Benzonitrile derivatives as kinase inhibitors
07/16/2014EP2753606A1 Pyrimidines as sodium channel blockers
07/16/2014EP2753604A1 Pde10 modulators
07/16/2014CN203710735U 一种高温煮沸烟碱提取装置 A high-temperature boiling nicotine extraction device
07/16/2014CN103930418A 金属酶抑制剂化合物 Metal inhibitor compound
07/16/2014CN103930416A 作为激酶抑制剂的苄腈衍生物 Benzonitrile derivatives as kinase inhibitors
07/16/2014CN103930415A 泛素特异性蛋白酶7的选择性和可逆性抑制剂 Ubiquitin-specific protease selective and reversible inhibitor of 7
07/16/2014CN103930414A 7-{(3s,4s)-3-[(环丙基氨基)甲基]-4-氟吡咯烷-1-基}-6-氟-1-(2-氟乙基)-8-甲氧基-4-氧-1,4-二氢喹啉-3-羧酸晶体 7 - {(3s, 4s) -3 - [(cyclopropylamino) methyl] -4-fluoro-pyrrolidin-1-yl} -6-fluoro-1- (2-fluoroethyl) 8- oxy-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid crystals
07/16/2014CN103930408A 用于癌症治疗的吗啉基苯并三嗪 For cancer treatment morpholine benzene and triazine
07/16/2014CN103930407A 用作激酶活性调节剂的氨基嘧啶衍生物 Modulators of kinase activity is used as an amino pyrimidine derivative
07/16/2014CN103930404A 用于抗疟疾治疗方法的取代的2-烷基-1-氧代-n-苯基-3-杂芳基-1,2,3,4-四氢异喹啉-4-酰胺 2-alkyl substituted-1-oxo antimalarial treatment method for -n- phenyl-3-heteroaryl-1,2,3,4-tetrahydro-isoquinoline-4-carboxamide
07/16/2014CN103930401A 杀虫化合物 Insecticidal compounds
07/16/2014CN103923080A 一种制备抗血栓药物阿哌沙班的方法 A method of preparing an anti-thrombotic drug apixaban in
07/16/2014CN103923066A 多靶点抗肿瘤化合物及其制备方法和应用 Multi-targeted anti-tumor compound and its preparation method and application
07/16/2014CN103923065A 三联吡啶衍生物及其在白光有机电致发光二极管中的应用 Terpyridine derivatives and the white light emitting organic electroluminescent diode Application
07/16/2014CN103923064A 一种纯化2-[(4-氯苯基)(哌啶-4-氧基)甲基]吡啶的方法 Pyridine method [(piperidin-4-yloxy) methyl (4-chlorophenyl)] - 2 for the purification of
07/16/2014CN103923063A 一种苯甲酸阿格列汀的新晶型及其制备方法 One kind of alogliptin new polymorph benzoic acid and its preparation method
07/16/2014CN103923021A 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound
07/16/2014CN103922883A 基于烃的稠环化合物和使用该化合物的有机发光器件 Condensed ring hydrocarbon-based compounds and the use of organic light emitting device of the compound
07/16/2014CN103922877A 双水相体系手性拆分拉唑类化合物 ATPS Chiral Separation pull azole
07/16/2014CN102970869B 吲哚 Indole
07/16/2014CN102858746B 3，3- 二甲基四氢喹啉衍生物 3,3-dimethyl-tetrahydro-quinoline derivatives of
07/16/2014CN102850327B 一种制备达比加群酯的中间体及其制备方法和应用 A process for preparing dabigatran intermediates and preparation method and application
07/16/2014CN102834388B Cgrp受体拮抗剂 Cgrp receptor antagonist
07/16/2014CN102746275B 结晶型艾普拉唑钠及其制备方法 Ilaprazole crystalline sodium and its preparation method
07/16/2014CN102702173B 一种制备质子泵抑制剂硫醚中间体的方法 A method of proton pump inhibitor sulfide intermediate prepared
07/16/2014CN102399212B 一种右兰索拉唑晶型及其制备方法 One kind Dexlansoprazole crystal and preparation method
07/16/2014CN102351941B 对功能分子进行<sup>18</sup>F标记的方法 Functional molecules <sup> Method 18 </ sup> F-labeled
07/16/2014CN102225929B 一种稳定的盐酸法舒地尔水合物化合物 A stable fasudil hydrochloride hydrate compound
07/16/2014CN102199119B 肟酯光引发剂 Oxime ester photoinitiator
07/16/2014CN102197033B 吡咯化合物 Azole compound
07/16/2014CN102015682B 作为肾素抑制剂的3,4-取代的哌啶衍生物 A renin inhibitor, 3,4-substituted piperidine derivatives
07/16/2014CN101965341B 用于治疗由剪接异常引起的疾病的抑制剪接机理的化学分子 For the treatment of diseases caused by aberrant splicing splicing mechanism of inhibition of chemical molecules
07/16/2014CN101790524B 抗病毒化合物 Antiviral compounds
07/16/2014CN101663261B 杀虫的芳基吡咯烷类化合物 Insecticidal aryl pyrrolidines compound
07/16/2014CN101580504B 有机化合物、苯并噁唑衍生物、以及使用其的发光元件 Organic compounds, benzoxazole derivatives, and the use of its light-emitting element
07/16/2014CN101538246B 作为pgds抑制剂的嘧啶酰胺化合物 As an inhibitor of pyrimidine amide compounds pgds
07/15/2014US8779159 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production
07/15/2014US8779158 Trisubstituted pyrazoles as acetylcholine receptor modulators
07/15/2014US8779149 Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators
07/15/2014US8779148 Fluoro-pyridinone derivatives useful as antibacterial agents
07/15/2014US8779147 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
07/15/2014US8779145 Process for the preparation of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline
07/15/2014US8779133 Compound, novel ligand, novel transition metal complex, and catalyst including novel transition metal complex
07/15/2014US8779127 Processes for preparing substituted pyrimidines
07/15/2014US8778977 Pyridinonyl PDK1 inhibitors
07/15/2014US8778975 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
07/15/2014US8778974 Trisubstituted 1,2,4 triazoles
07/15/2014US8778972 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1
07/15/2014US8778967 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/15/2014US8778966 Quinolinone derivatives as PARP and tank inhibitors
07/15/2014US8778955 Indole derivatives or benzimidazole derivatives for modulating IkB kinase
07/15/2014US8778954 Phenylpyridine derivative and medicinal agent comprising same
07/15/2014US8778950 Cannabinoid receptor modulators
07/15/2014US8778941 TRPM8 antagonists and their use in treatments
07/15/2014US8778931 Substituted hydroxamic acids and uses thereof
07/15/2014US8778929 Substituted heteroaryl inhibitors of B-RAF
07/15/2014US8778628 Arylalkylamine compound and process for preparing the same
07/15/2014US8778625 2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
07/15/2014CA2753434C Soluble guanylate cyclase activators
07/15/2014CA2745004C Pyridine-3-carboxyamide derivative
07/15/2014CA2584185C Heterocyclic substituted bisarylurea derivates as kinase inhibitors
07/10/2014WO2014107622A1 Deoxyuridine triphosphatase inhibitors
07/10/2014WO2014106622A1 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders
07/10/2014WO2014106612A1 Aminopyridine derived compounds as lrrk2 inhibitors
07/10/2014WO2014106606A1 Nove phenyl/pyridine series substitued by hydroxyethylamino for the treatment of cancer
07/10/2014WO2014062658A8 Methylene linked quinolinyl modulators of ror-gamma-t
07/10/2014WO2014059518A9 Solid forms of nilotinib hydrochloride
07/10/2014WO2014057080A3 N-(2-(cyclic amine)ethyl)benzamide derivatives as p2x7 inhibitors
07/10/2014WO2014030002A3 Molecularly imprinted polymers for the capture of biotin
07/10/2014US20140194623 Process for preparing tetrazole-substituted anthranilic acid diamide derivatives by reacting benzoxazinones with amines
07/10/2014US20140194472 Vitamin d receptor-coregulator inhibitors
07/10/2014US20140194471 Substituted 1-benzylindolin-2-one analogs as positive allosteric modulators of muscarinic acetylcholine m1 receptors
07/10/2014US20140194470 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/10/2014US20140194469 Histone demethylase inhibitors
07/10/2014US20140194465 Compositions for treatment of cancer
07/10/2014US20140194452 Pyrazolyl-Based Carboxamides II
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 1080